Anti-unlcer and antimicrobial activities of sodium selenite against Helicobacter pylori: In vitro and in vivo evaluation

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 4, 2010, Pages 266-274

  Kumar, B Santhosh ^a   Tiwari, Santosh K ^b   Manoj, G ^b   Kunwar, Amit ^c   Amrita, N ^b   Sivaram, G ^b   Abid, Zakia ^a   Ahmad, Adeel ^d   Khan, Aleem A ^b   Priyadarsini, K Indira ^c  

^a DECCAN COLLEGE OF MEDICAL SCIENCES   (India)

^b DECCAN COLLEGE OF MEDICAL SCIENCES   (India)

^c BHABHA ATOMIC RESEARCH CENTRE   (India)

^d OSMANIA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; CLARITHROMYCIN; NAPROXEN; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; DISK DIFFUSION; DRUG ACTIVITY; DRUG EFFICACY; FLOW CYTOMETRY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; RAT; ULCER HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; RATS; RATS, WISTAR; SODIUM SELENITE;

EID: 77949458967     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903493707     Document Type: Article

References (34)

1. Kohrl J, Brigelius-Flohe R, Bock A, Gartner R, Meyer O, Flohe L. Selenium in biology: facts and medical perspectives. Biol Chem 2000;381:849-864
2. Soriano-Garcia M. Organoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr Med Chem 2004;11:1657-1669
3. Fiskin K, Ozkan A, Ayhan AG. Investigation of protective effects of selenium and vitamin E against DNA oxidation, membrane damage and alteration of COMT metabolism in smoke-exposed male mice (Mus musculus, Balb/c). Acta Biol Hung 2006;57:403-413
4. Banner WP, DeCosse JJ, Tan QH, Zedeck MS. Selective distribution of selenium in colon parallels its antitumor activity. Carcinogenesis 1984;5:1543-1546
5. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991;302:1302-1305
6. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131
7. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-1271
8. Asaka M, Takeda H, Sugiyama T, Kato M. What role does Helicobacter pylori play in gastric cancer? Gastroenterology 1997;113:S56-60.
9. Manoj G, Tiwari SK, Sharma V, Habeeb MA, Khan AA, Habibullah CM. Association of Helicobacter pylori restriction endonuclease-replacing gene, hrg A with overt gastrointestinal diseases. Arq Gastroenterol 2008;43:225-229
10. Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999;13:489-496
11. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312
12. Slootmans IL, Dirk A, Berghe V, Dyck EV, Piot P. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products. Antimicrob Agents Chemother 1983; 24:564-567
13. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998;128:1845-1854
14. Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, et al. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob 2005; 4:20.
15. Ibrahim M, Khan AA, Tiwari SK, Habeeb MA, Khaja MN, Habibullah CM. Antimicrobial activity of Sapindus mukorossi and Rheum emodi extracts against H. pylori: in vitro and in vivo studies. World J Gastroenterol 2006;12: 7136-7142
16. Tiwari SK, Khan AA, Manoj G, Ahmed S, Abid Z, Habeeb A, Habibullah CM. A simple multiplex PCR assay for diagnosing virulent Helicobacter pylori infection in human gastric biopsy specimens from subjects with gastric carcinoma and other gastro-duodenal diseases. J Appl Microbiol 2007;103:2353-2360
17. Tiwari SK, Manoj G, Kumar GV, Sivaram G, Hassan SI, Prabhakar B, et al. Prognostic significance of genotyping Helicobacter pylori infection in patients in younger age groups with gastric cancer. Postgrad Med J 2007;84:193-197
18. Clayton CL, Mobley HL. Methods in molecular medicine. H. pylori protocols. 1 st ed. Totowa: Humana Press Inc.; 1997. pp 6:41-51.
19. Alberto AB, Aviera A, Rafael C, Cesar N, Miguel S. Applications of flow cytometry to clinical microbiology. Clin Microb Rev 2000;13:167-195
20. Elliott SN, Buret A, McKnight W, Miller MJ, Wallace JL. Bacteria rapidly colonize and modulate healing of gastric ulcers in rats. Am J Physiol Gastrointest Liver Physiol 1998; 275:425-432
21. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3 rd ed. Approved standard M7-A3. Wayne, PA: NCCLS; 1993.
22. Li H, Kalies I, Mellgård B. A rat model of chronic Helicobacter pylori infection. Studies of epithelial cell turnover and gastric ulcer healing. Scand J Gastroenterol 1998; 33:370-378
23. Suzuki H, Mori M, Seto K, Kai A, Kawaguchi C, Suzuki M, et al. Helicobacter pylori-associated gastric pro-and antioxidant formation in Mongolian gerbils. Free Radic Biol Med 1999;26:679-684
24. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-1171
25. Ahmed N, Sechi LA. Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrob 2005;4:1.
26. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374-1384
27. Holecek V, Rokyta R, Vlasak R. Antioxidants and their gastrointestinal absorption and interferences of their effects. Cesk Fysiol 2008;57:24-32.
28. Lipinski B. Rationale for the treatment of cancer with sodium selenite. Med Hypotheses 2005;64:806-810
29. Yang G, Zhou R. Further observation on the human maximum safe dietary selenium intake in a selenferous area in China. J Trace Elem Electrolytes Health Dis 1994;8:159-165
30. Parmar NS, Tariq M, Ageel AM. Gastric anti-ulcer and cytoprotective effect of selenium in rats. Toxicol Appl Pharmacol 1988;92:122-130
31. Zhong, W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001;61:7071-7078
32. Su YP, Tang JM, Tang Y, Gao HY. Histological and ultrastructural changes induced by selenium in early experimental gastric carcinogenesis. World J Gastroenterol 2005;11: 4457-4460
33. Roden M, Prskavec M, Furnsinn C, Elmadfa I, Konig J, Schneider B, et al. Metabolic effect of sodium selenite: insulin-like inhibition of glucagon-stimulated glycogenolysis in the isolated perfused rat liver. Hepatology 1995;22: 169-174
34. Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KL, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 1996;17:559-562